Valuation: ALK-Abelló A/S

Capitalization 5.6TCr 871.12Cr 749.6Cr 685.37Cr 653.91Cr 1.2TCr 84TCr 1.22TCr 8.22TCr 3.18TCr 40TCr 3.27TCr 3.2TCr 1,38200Cr P/E ratio 2026 *
38.8x
P/E ratio 2027 * 34.1x
Enterprise value 5.43TCr 844.3Cr 726.52Cr 664.27Cr 633.78Cr 1.16TCr 81TCr 1.18TCr 7.97TCr 3.08TCr 38TCr 3.17TCr 3.1TCr 1,34000Cr EV / Sales 2026 *
7.46x
EV / Sales 2027 * 6.46x
Free-Float
59.15%
Yield 2026 *
0.68%
Yield 2027 * 0.74%
1 day-1.46%
1 week-0.32%
Current month+4.61%
1 month+11.74%
3 months+14.19%
6 months+6.49%
Current year+9.10%
1 week 248.4
Extreme 248.4
255
1 month 208
Extreme 208
262
Current year 192.7
Extreme 192.7
262
1 year 169
Extreme 169
262
3 years 69.9
Extreme 69.9
262
5 years 69.9
Extreme 69.9
262
10 years 32.3
Extreme 32.3
262
Manager TitleAgeSince
Chief Executive Officer 49 01/01/2024
Director of Finance/CFO 54 01/06/2023
Human Resources Officer - 01/10/2019
Director TitleAgeSince
Director/Board Member 57 01/01/2011
Director/Board Member 67 01/01/2014
Director/Board Member 66 12/03/2015
Change 5d. change 1-year change 3-years change Capi.($)
-1.46%-0.32%+45.85%+187.99% 871.12Cr
-0.18%+5.95%+32.68%+129.71% 90TCr
-1.77%+2.44%+49.81%+42.59% 55TCr
-0.18%+4.39%+14.33%+46.77% 37TCr
-0.60%+2.38%+24.30%+13.90% 33TCr
+0.36%+3.04%+27.97%+29.44% 28TCr
+0.58%+1.50%+32.12%+14.41% 28TCr
-1.79%0.00%+46.44%-2.95% 28TCr
-3.89%-4.08%-34.41%-51.22% 21TCr
-2.95%-1.62%+19.79%+45.01% 18TCr
Average -0.89%+1.88%+25.89%+45.57% 33.72TCr
Weighted average by Cap. -0.52%+3.16%+28.55%+51.01%

Financials

2026 *2027 *
Net sales 727.65Cr 113.17Cr 97Cr 89Cr 85Cr 155.74Cr 11TCr 158.31Cr 1.07TCr 413.36Cr 5.15TCr 424.7Cr 415.6Cr 18TCr 825.72Cr 128.42Cr 110.51Cr 101.04Cr 96Cr 176.73Cr 12TCr 179.65Cr 1.21TCr 469.07Cr 5.85TCr 481.94Cr 471.62Cr 20TCr
Net income 144.4Cr 22Cr 19Cr 18Cr 17Cr 31Cr 2.15TCr 31Cr 211.99Cr 82Cr 1.02TCr 84Cr 82Cr 3.56TCr 163.88Cr 25Cr 22Cr 20Cr 19Cr 35Cr 2.45TCr 36Cr 240.58Cr 93Cr 1.16TCr 96Cr 94Cr 4.04TCr
Net Debt -172.43Cr -27Cr -23Cr -21Cr -20Cr -37Cr -2.57TCr -38Cr -253.14Cr -98Cr -1.22TCr -100.64Cr -98Cr -4.26TCr -270.5Cr -42Cr -36Cr -33Cr -32Cr -58Cr -4.04TCr -59Cr -397.11Cr -153.66Cr -1.92TCr -157.88Cr -154.5Cr -6.68TCr
Logo ALK-Abelló A/S
ALK-Abello A/S is a Denmark-based company active within the pharmaceutical industry. It is engaged in the development and marketing of pharmaceutical products for the treatment, prevention and diagnosis of allergy. Its product portfolio comprises allergy vaccines, emergency treatments and allergy diagnostics products. The Company’s allergy vaccines product offering comprises tablet vaccines, sublingual vaccines and subcutaneous vaccines. Its emergency treatments product offering comprises products for the management of anaphylaxis. Its allergy diagnostics product offering comprises allergen extracts for allergy testing, such as skin-prick tests. The Company operates worldwide through subsidiaries, production units and distributors in such countries as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States and China.
Employees
2,759
Date Price Change Volume
18/26/18 249.40 kr -1.34% 74,061
13/26/13 252.80 kr +0.64% 1,68,148
12/26/12 251.20 kr +0.40% 1,98,397
11/26/11 250.20 kr -2.11% 2,67,830
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
252.80DKK
Average target price
295.00DKK
Spread / Average Target
+16.69%

Quarterly revenue - Rate of surprise